Back to Screener
OLMA

Olema Pharmaceuticals, Inc.

OLMANASDAQ🇺🇸

Healthcare · Biotechnology

$15.06 9.31%

Last updated: 1d ago

52-Week Range

$2.86
$36.26

Company Overview

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in

Valuation

PER (TTM)
Forward PER-6.37
PBR3.28
PSR
EV/EBITDA-4.29
Market Cap$1.21B

Profitability

ROE-59.23%
ROA-34.41%
Net Margin0.00%
Operating Margin0.00%

Growth & Stability

Revenue Growth
Earnings Growth
Debt-to-Equity1.5
Current Ratio8.03
Beta2.02

Dividends

Dividend Yield
Payout Ratio0.0%

Trading Info

Prev Close$16.60
Volume1.6M
Avg Volume1.7M
Employees122